Candesartan is a medication classified as an angiotensin receptor blocker used to treat high blood pressure. It works by blocking the action of a hormone that causes blood vessels to tighten. By relaxing the vessels the drug helps the heart pump blood more easily and reduces pressure on the circulatory system. The active ingredient binds to a specific receptor on cells that normally responds to angiotensin ii. This binding prevents the signal that would normally raise blood pressure and promotes fluid balance. The overall effect is a sustained lowering of blood pressure and improved heart function.

Candesartan is a selective angiotensin ii receptor antagonist used in the treatment of hypertension and heart failure. Its pharmacological profile includes high affinity binding to the at1 receptor blocking the vasoconstrictive effects of angiotensin ii. This inhibition leads to vasodilation reduced aldosterone secretion and improved cardiac remodeling. The drug is absorbed with high bioavailability and distributes widely with a prolonged elimination half life. Its active metabolite Candesartan carboxylic acid contributes to sustained receptor blockade throughout the dosing interval. The resulting modulation of the renin angiotensin system provides predictable blood pressure control without direct influence on heart rate.

Common side effects include mild headache and occasional dizziness. Some people may experience temporary fatigue that usually resolves within a short period. Digestive discomfort such as nausea or mild stomach upset can occur. Skin reactions like mild itching or redness are reported occasionally. Sleep disturbances such as difficulty falling asleep may happen. Increased heart rate is noted in a small percentage of users. Mild muscle aches have been observed in some cases. Most of these effects are short lived and tend to diminish as the body adjusts.

The most common side effects are mild and often short lived. They may include temporary fatigue headache and mild fever. Some people experience occasional soreness at the injection site. Digestive disturbances such as nausea or diarrhea can also occur. These reactions usually resolve within a few days. The frequency of each symptom varies by age and health status. Serious complications are rare and are monitored closely in clinical studies. Overall the safety profile remains consistent across diverse populations.